Search clinical trials for: recurrent venous thromboembolism

Total 15640 results

Imperial College London

Recruiting

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) (THRIVE)

Varicose Veins | Venous Thromboembolism

United Kingdom
Academisch Medisch Centrum - Universiteit van Amsterdam...
G. d'Annunzio University

Recruiting

Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study (REDUCE)

Recurrence | Cancer | Venous Thromboembolism

Spain, Italy, Netherlands
Arianna Anticoagulazione Foundation

Recruiting

Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) (Jason)

Venous Thromboembolism | Elderly | Anticoagulant

Italy
Medical University of Vienna

Recruiting

Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism (AURECpro)

Recurrent Venous Thrombosis

Austria
Fundació Institut de Recerca de l'Hospital de la...
Daiichi Sankyo

Recruiting

Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD) (MACACOD)

Atrial Fibrillation | Recurrent Venous Thromboembolism

Spain
University Hospital, Brest

Recruiting

Six Years of Follow-up After Idiopathic Venous Throbmoembolism (Padis-Ext)

Pulmonary Embolism | Proximal Deep Vein Thrombosis

France
University Hospital, Brest
University Hospital of Saint-Etienne

Completed

REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism. (RENOVE)

Venous Thromboembolism

France
Bayer

Completed

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort (OSCAR-US)

Treatment of Venous Thromboembolism in Cancer Patients | Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients

United States
Bayer
Janssen Research & Development, LLC

Completed

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer (COSIMO)

Venous Thrombosis and Pulmonary Embolism

Italy, Germany, United Kingdom, France, Belgium, Canada, Netherlands, Spain, Denmark, Australia
Medical University of Vienna

Completed

Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction Model

Venous Thromboembolism

Austria
Instituto Mexicano del Seguro Social

Completed

Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

Venous Thromboembolism | Pulmonary Embolism | Anticoagulant-induced Bleeding | Venous Thromboses

Mexico
Academisch Medisch Centrum - Universiteit van Amsterdam...
Netherlands Organisation for Scientific Research; Aspen Pharma; CHU of Saint... and other collaborators

Completed

Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy (Highlow)

Pulmonary Embolism | Deep Venous Thrombosis

Norway, Netherlands, Denmark, France, Belgium, Ireland, United States, Canada, Russian Federation, Spain
Bristol-Myers Squibb

Completed

ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE

Venous Thromboembolism

Japan
Ottawa Hospital Research Institute

Completed

Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS) (PREDICTORS)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Thromboembolic Disease Recurrent | Recurrent Thromboembolic Disease

Canada, Netherlands, Switzerland
University Hospital, Brest
Bristol-Myers Squibb

Unknown

Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism. (DEBRIEF-VTE)

Venous Thromboembolism

France
Daiichi Sankyo, Inc.

Completed

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Venous Thrombosis | Thromboembolism | Venous Thromboembolism | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE)

France, United States, Japan, Denmark, Italy, Russian Federation, Czechia, Germany, India, Israel, Philippines, Taiwan, Ukraine, Australia, Austria, China, Argentina, Belarus, Belgium, Brazil, Canada, Chile, Estonia, Hungary, Korea, Republic... and more
Bayer
Janssen Research & Development, LLC

Completed

Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban

Venous Thromboembolism

United States
Bayer
Janssen Scientific Affairs, LLC

Completed

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) (EinsteinChoice)

Thrombosis | Venous Thrombosis | Thromboembolism | Venous Thromboembolism | Pulmonary Embolism

Belgium, France, China, Switzerland, New Zealand, South Africa, Hungary, United States, Canada, Australia, Netherlands, Spain, Russian Federation, Austria, Mexico, Taiwan, Brazil, Czechia, Denmark, Germany, Israel, Italy, Korea, Republic... and more
Bristol-Myers Squibb

Completed

Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS

Venous Thromboembolism

Korea, Republic of
University Hospital, Brest

Completed

Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study. (PADIS EP)

Pulmonary Embolism

France
University Hospital, Brest

Completed

Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP) (PADIS TVP)

Recurrent Venous Thromboembolism | Idiopathic Deep Vein Thrombosis

France
Ottawa Hospital Research Institute
BioMérieux; Centre Hospitalier Régional et Universitaire de Brest

Completed

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism (REVERSEII)

Idiopathic Venous Thromboembolism

United States, Canada, Australia, Belgium, France, India, Switzerland
University of Padova

Completed

Optimal Duration of Anticoagulation in Deep Venous Thrombosis (MORGAGNI)

Deep Vein Thrombosis of Lower Limb | Lower Extremity Deep Venous Thrombosis Recurrent

Italy
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Prevention of Recurrent Venous Thromboembolism (PREVENT)

Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Peripheral Vascular Diseases | Thromboembolism | Venous Thromboembolism
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation... and other collaborators

Unknown

Understanding Risk Factors Involved in Developing a Second Blood Clot.

Deep Vein Thrombosis

Canada, France
University Medical Center Groningen

Terminated

Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism (Longheva)

Neoplasms | Venous Thromboembolism

Netherlands, United States, Canada, Italy, Germany
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study

Venous Thromboembolism

United Kingdom, Belgium, France, Israel, Italy, Spain, China, Hong Kong, Korea, Republic of, New Zealand, Poland, India, United States, Hungary, Singapore, Canada, Australia, Netherlands, Austria, Switzerland, Taiwan, Brazil, Denmark, German... and more
Boehringer Ingelheim

Completed

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE (RE-SONATE)

Venous Thromboembolism

United States, Australia, Austria, Belgium, Canada, Czech Republic, Estonia, Germany, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Russian Federation, Singapore, South Africa, Sweden, Switzer... and more
Novartis

Completed

Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis

Multiple Sclerosis

Greece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
University Of Perugia

Unknown

Aspirin for the Prevention of Recurrent Venous Thromboembolism

Atherosclerosis | Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Italy, Austria
Hamilton Health Sciences Corporation
Heart and Stroke Foundation of Canada

Terminated

D-Dimer and IPG for Recurrent Thrombosis (DIRECT)

Deep Vein Thrombosis | Pulmonary Embolism

Canada, Italy
Deborah Siegal

Not yet recruiting

Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism

Venous Thromboembolism | Blood Clot | Gastro Intestinal Bleeding
University Hospital, Brest

Not yet recruiting

Cancer-related Venous Thromboembolic Disease - Cohort Study (CAPE)

Cancer | Thromboses, Venous | Thrombosis Embolism
Navy General Hospital, Beijing

Not yet recruiting

Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism (SmaPE)

Venous Thromboembolism | Clinical Decision Support Systems | Digital Health | Pulmonary Thromboembolisms

China
University Hospital, Brest

Not yet recruiting

Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT) (PRONOSPECT)

Venous Thromboembolism | Pulmonary Embolism

France
Medical University of Vienna

Not yet recruiting

Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients (AntiXa-ICU)

Thrombosis | Pulmonary Embolism | Enoxaparin
Navy General Hospital, Beijing

Not yet recruiting

Smart Technology Facilitated Venous Thromboembolism Prophylaxis Based on Bundled Evidence-based Prevention Strategies (SmaVTE-BEST)

Venous Thromboembolism | Clinical Decision Support Systems | Digital Health
Navy General Hospital, Beijing

Not yet recruiting

Smart Technology Facilitated Patient-centered Venous Thromboembolism Management (SmaVTE-RCT)

Venous Thromboembolism | Health Education | Digital Health

China
Navy General Hospital, Beijing

Not yet recruiting

Smart Technology Facilitated Patient-centered Venous Thromboembolism Management (SmaVTE-COR)

Venous Thromboembolism | Health Education | Digital Health

China
Khon Kaen University

Recruiting

5E Program for Preventing Venous Thromboembolism in Patients With Spinal Cord Disorders

Spinal Cord Diseases | Venous Thromboembolism | Spinal Cord Injuries | Nurse's Role

Thailand
Regeneron Pharmaceuticals

Not yet recruiting

A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC) (ROXI-CATH)

Venous Thromboembolism
Gia Dinh People Hospital

Not yet recruiting

MEdication Counselling Models for Outpatient oRal antIcoaguLation (MEMORIAL)

Anticoagulants; Circulating, Hemorrhagic Disorder
Fondazione Policlinico Universitario Agostino Gemelli...
Fondazione Umberto Veronesi

Not yet recruiting

Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study (GynCAT)

Gynecologic Cancer | Ovarian Cancer | Venous Thromboembolism | Cervix Cancer | Endometrial Cancer | Vaginal Cancer | Cancer-associated Thrombosis

Italy
Bayer
Janssen Pharmaceutical Companies (formerly Johnson & Johnson Pharmaceutical...

Recruiting

An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism

Venous Thromboembolism

Japan
Centre Hospitalier Universitaire de Saint Etienne

Recruiting

The Role of Platelet TLRs in Platelet Activation During VTE (ROT-PLAT-VTE)

Venous Thromboembolism

France
NewAmsterdam Pharma
Novum

Recruiting

Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib

Healthy Volunteers

United States
Scott C. Woller, MD
Janssen Pharmaceuticals

Not yet recruiting

Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism (eVTE)

Deep Vein Thrombosis | Hospitalism | Venous Thromboembolic Disease | Pulmonary Embolism and Thrombosis

United States
Beijing Suncadia Pharmaceuticals Co., Ltd

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery

Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
Nanfang Hospital, Southern Medical University

Recruiting

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Glioma, Malignant

China
Dr. Kerstin de Wit
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...

Recruiting

Improving Emergency Department Testing for Deep Vein Thrombosis

Deep Vein Thrombosis (DVT)

Canada

Search clinical trials for: recurrent venous thromboembolism

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations